The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-𝛼 Therapy for Chronic Hepatitis C

Figure 2

The proposed hypotheses for the development of the full spectrum of thyroid diseases after the completion of combination IFN-based therapy. IL-6: Interleukin-6; IFN: Interferon; MHC-II: major histocompatability complex-II; GD: Graves’ disease; T_H: T helper.